Abpro (ABP) Competitors $0.23 -0.02 (-8.97%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock ABP vs. RENB, KLTO, UNCY, RPTX, ASRT, NRXP, CLSD, XCUR, VHAQ, and PMVPShould you be buying Abpro stock or one of its competitors? The main competitors of Abpro include Renovaro (RENB), Klotho Neurosciences (KLTO), Unicycive Therapeutics (UNCY), Repare Therapeutics (RPTX), Assertio (ASRT), NRx Pharmaceuticals (NRXP), Clearside Biomedical (CLSD), Exicure (XCUR), Viveon Health Acquisition (VHAQ), and PMV Pharmaceuticals (PMVP). These companies are all part of the "pharmaceutical products" industry. Abpro vs. Its Competitors Renovaro Klotho Neurosciences Unicycive Therapeutics Repare Therapeutics Assertio NRx Pharmaceuticals Clearside Biomedical Exicure Viveon Health Acquisition PMV Pharmaceuticals Abpro (NASDAQ:ABP) and Renovaro (NASDAQ:RENB) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation, profitability and community ranking. Which has more risk & volatility, ABP or RENB? Abpro has a beta of -0.03, indicating that its share price is 103% less volatile than the S&P 500. Comparatively, Renovaro has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Do insiders and institutionals hold more shares of ABP or RENB? 23.3% of Abpro shares are held by institutional investors. Comparatively, 71.4% of Renovaro shares are held by institutional investors. 20.8% of Abpro shares are held by insiders. Comparatively, 21.7% of Renovaro shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is ABP or RENB more profitable? Abpro's return on equity of 0.00% beat Renovaro's return on equity.Company Net Margins Return on Equity Return on Assets AbproN/A N/A N/A Renovaro N/A -61.84%-48.07% Does the MarketBeat Community favor ABP or RENB? Abpro received 1 more outperform votes than Renovaro when rated by MarketBeat users. CompanyUnderperformOutperformAbproOutperform Votes1100.00% Underperform VotesNo VotesRenovaroN/AN/A Which has better earnings & valuation, ABP or RENB? Abpro has higher revenue and earnings than Renovaro. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbpro$183K76.83N/AN/AN/ARenovaroN/AN/A-$80.65M-$0.77-0.49 Does the media favor ABP or RENB? In the previous week, Renovaro had 1 more articles in the media than Abpro. MarketBeat recorded 2 mentions for Renovaro and 1 mentions for Abpro. Abpro's average media sentiment score of 1.87 beat Renovaro's score of 0.39 indicating that Abpro is being referred to more favorably in the media. Company Overall Sentiment Abpro Very Positive Renovaro Neutral Do analysts recommend ABP or RENB? Abpro currently has a consensus target price of $4.00, indicating a potential upside of 1,629.36%. Given Abpro's stronger consensus rating and higher probable upside, equities research analysts plainly believe Abpro is more favorable than Renovaro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abpro 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Renovaro 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryAbpro beats Renovaro on 8 of the 12 factors compared between the two stocks. Get Abpro News Delivered to You Automatically Sign up to receive the latest news and ratings for ABP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ABP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABP vs. The Competition Export to ExcelMetricAbproHolding Offices IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.06M$487.13M$5.61B$8.62BDividend YieldN/A7.69%5.28%4.18%P/E RatioN/A2.5327.1419.96Price / Sales76.8383.44411.83157.63Price / CashN/A69.0138.2534.64Price / BookN/A6.437.064.69Net IncomeN/A$35.76M$3.23B$248.14M7 Day Performance8.95%2.76%2.67%2.39%1 Month Performance10.25%4.14%8.82%6.05%1 Year PerformanceN/A44.69%31.44%13.60% Abpro Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABPAbproN/A$0.23-9.0%$4.00+1,629.4%N/A$14.06M$183K0.0015Positive NewsGap DownRENBRenovaro1.7666 of 5 stars$0.38+5.6%N/A-76.4%$65.49MN/A-0.4120High Trading VolumeKLTOKlotho NeurosciencesN/A$2.01+10.4%N/AN/A$65.31MN/A-5.58N/AGap UpHigh Trading VolumeUNCYUnicycive Therapeutics3.5935 of 5 stars$0.53-40.9%$6.00+1,027.6%-3.8%$64.19M$680K-0.559News CoverageShort Interest ↓Analyst RevisionGap UpHigh Trading VolumeRPTXRepare Therapeutics2.4473 of 5 stars$1.48+0.7%$4.50+204.1%-62.1%$63.48M$1.07M-0.74180Positive NewsASRTAssertio2.4466 of 5 stars$0.66+0.4%$2.75+316.1%-39.6%$63.30M$119.00M-0.9120Positive NewsNRXPNRx Pharmaceuticals2.1238 of 5 stars$3.65-0.5%$28.50+680.8%+4.8%$63.11MN/A-1.712CLSDClearside Biomedical2.7068 of 5 stars$0.81+6.4%$4.80+492.6%-35.4%$62.94M$3.76M-1.8030Positive NewsShort Interest ↓XCURExicure1.6526 of 5 stars$9.89+1.9%N/A+2,568.6%$62.48M$500K-4.7850Positive NewsUpcoming EarningsVHAQViveon Health AcquisitionN/A$11.00flatN/AN/A$62.26MN/A0.002High Trading VolumePMVPPMV Pharmaceuticals2.448 of 5 stars$1.19+12.3%$5.50+362.2%-34.7%$61.82MN/A-1.1950Positive NewsHigh Trading Volume Related Companies and Tools Related Companies RENB Alternatives KLTO Alternatives UNCY Alternatives RPTX Alternatives ASRT Alternatives NRXP Alternatives CLSD Alternatives XCUR Alternatives VHAQ Alternatives PMVP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ABP) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abpro Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Abpro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ABP Stock Free ABP Stock Alerts